New Molecular Framework Shows RSV Activity
A new antiviral molecular framework has demonstrated effectiveness against Respiratory Syncytial Virus (RSV) and Hepatitis B. Researchers noted the framework is not applicable to all viruses.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
RTHK Radio 1 Cantonese
“In the viruses we have tested, we found that it has better activity against a respiratory virus called RSV, and also Hepatitis B.”
RTHK Radio 1 Hong Kong
“This new antiviral molecular framework... we found it has good activity against a respiratory virus called RSV, as well as Hepatitis E virus.”
RTHK Radio 1 Cantonese
“在我們測試過的病毒之中 我們發覺對一種呼吸道病毒 叫RSV呼吸道合包病毒 是有比較好的活性 還有越人肝炎的病毒都是有比較好的”
RTHK Radio 1 Hong Kong
“這隻新型抗病毒分子骨架 是否都可以廣泛應用所有抗病毒藥物 其實不可以說全部病毒都有用 在我們測試過的病毒之中 我們發覺對一種呼吸道病毒叫RSV 呼吸道核包病毒是有比較好的活性 以及越人肝炎的病毒也是有比較好的”
RTHK Radio 1 Hong Kong
“In the viruses we have tested, we found it has good activity against a respiratory virus called RSV and Hepatitis B.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade